Zoetis (NYSE:ZTS) Given New $200.00 Price Target at Stifel Nicolaus

Zoetis (NYSE:ZTS) had its price target raised by Stifel Nicolaus from $180.00 to $200.00 in a report published on Monday morning, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock.

Several other equities research analysts have also recently commented on ZTS. BTIG Research initiated coverage on shares of Zoetis in a research report on Thursday, July 25th. They issued a buy rating and a $220.00 price target on the stock. Piper Sandler reaffirmed an overweight rating and set a $195.00 target price (down from $220.00) on shares of Zoetis in a report on Tuesday, April 16th. HSBC lowered their price objective on shares of Zoetis from $230.00 to $225.00 and set a buy rating on the stock in a research report on Wednesday, May 8th. Barclays decreased their target price on Zoetis from $260.00 to $230.00 and set an overweight rating for the company in a research report on Tuesday, April 23rd. Finally, The Goldman Sachs Group lowered their target price on Zoetis from $223.00 to $196.00 and set a buy rating on the stock in a research note on Monday, May 6th. Nine research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has a consensus rating of Buy and an average target price of $214.89.

Zoetis Price Performance

NYSE:ZTS traded up $10.47 during midday trading on Monday, hitting $185.29. 3,740,654 shares of the stock were exchanged, compared to its average volume of 2,807,865. Zoetis has a one year low of $144.80 and a one year high of $201.92. The company has a current ratio of 3.33, a quick ratio of 1.94 and a debt-to-equity ratio of 1.30. The business has a 50-day moving average price of $175.53 and a two-hundred day moving average price of $175.38. The company has a market capitalization of $84.55 billion, a price-to-earnings ratio of 36.44, a P/E/G ratio of 2.80 and a beta of 0.86.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 4th. Stockholders of record on Thursday, July 18th will be given a dividend of $0.432 per share. This represents a $1.73 annualized dividend and a dividend yield of 0.93%. The ex-dividend date of this dividend is Thursday, July 18th. Zoetis’s dividend payout ratio is 33.33%.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Blue Bell Private Wealth Management LLC increased its position in shares of Zoetis by 222.5% during the fourth quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock worth $25,000 after acquiring an additional 89 shares in the last quarter. Private Wealth Management Group LLC acquired a new stake in Zoetis in the 4th quarter valued at approximately $33,000. Webster Bank N. A. lifted its stake in Zoetis by 89.1% in the 1st quarter. Webster Bank N. A. now owns 174 shares of the company’s stock valued at $29,000 after acquiring an additional 82 shares in the last quarter. Gladius Capital Management LP acquired a new position in Zoetis during the 4th quarter worth approximately $40,000. Finally, Neo Ivy Capital Management bought a new position in shares of Zoetis during the 4th quarter worth approximately $40,000. Institutional investors and hedge funds own 92.80% of the company’s stock.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.